Results 171 to 180 of about 22,412 (196)

Long-term outcomes of heparin-induced thrombocytopenia after cardiac surgery. [PDF]

JTCVS Open
Rodriguez E, Daskam M, Shou BL, Woodrum C, Gupta R, Dane KE, Alejo D, Sussman M, Schena S.   +8 more
europepmc   +1 more source

Case Report: Heparin-induced thrombocytopenia following double filtration plasmapheresis in a patient with anti-GAD65 autoimmune encephalitis. [PDF]

Front Cardiovasc Med
Chen Y, Li W, Ni L, Mei Y, Zhou Y, Wan W.   +5 more
europepmc   +1 more source

Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia. [PDF]

Blood Adv
Nilius H, Hamzeh-Cognasse H, Hastings J, Studt JD, Tsakiris DA, Greinacher A, Mendez A, Schmidt A, Wuillemin WA, Gerber B, Vishnu P, Graf L, Kremer Hovinga JA, Bakchoul T, Cognasse F, Cognasse F, Nagler M.   +16 more
europepmc   +1 more source

Heparin-Induced Thrombocytopenia in Patients Suffering Cardiogenic Shock. [PDF]

Crit Care Explor
Lüsebrink E, Lanz H, Binzenhöfer L, Hoffmann S, Höpler J, Kraft M, Gade N, Gmeiner J, Roden D, Saleh I, Hagl C, Nickenig G, Massberg S, Zimmer S, Jamin RN, Scherer C.   +15 more
europepmc   +1 more source

Heparin induced thrombocytopenia-type 2

Asian Journal of Transfusion Science, 2010
Majeed Tanveer
doaj  

Some of the next articles are maybe not open access.

Related searches:

Heparin-induced thrombocytopenia

Hämostaseologie, 2010
SummaryHeparin-induced thrombocytopenia (HIT), typically occurring in the second week of heparin therapy, is an antibody-mediated adverse drug reaction associated with increased thrombotic risk. The most important antigens are located on platelet factor 4 (PF4)/heparin complexes.
A, Greinacher, K, Althaus, K, Krauel, S, Selleng   +3 more
openaire   +4 more sources

Heparin-Induced Thrombocytopenia

International Anesthesiology Clinics, 2004
Heparin is widely used for the prevention and treatment of thrombotic and particularly cardiovascular disorders. Unfortunately, 0.5 to 3.0% of patients given heparin develop an immune reaction, commonly termed Type II heparin-induced thrombocytopenia (HIT).
Mark E, Comunale, Elizabeth M, Van Cott
openaire   +4 more sources

Heparin-induced Thrombocytopenia

Pathophysiology of Haemostasis and Thrombosis, 1986
Heparin-induced thrombocytopenia is the most frequent and the most important idiosyncratic haematological drug reaction. It is important for several reasons: first, because heparin is used so often, and the frequency of heparin-induced thrombocytopenia is high, the risk of a hospitalized patient developing heparin-induced thrombocytopenia is high ...
J G, Kelton, M N, Levine
openaire   +4 more sources

Heparin–induced thrombocytopenia

American Journal of Health-System Pharmacy, 1995
Heparin is one of the most frequently prescribed medications in the United States with more than 1 trillion units being used each year. However, some patients who receive heparin may have development of a rare but severe complication called heparin-induced thrombocytopenia, which is associated with significant morbidity and mortality rates.
D A, Borkowski, R W, Force
openaire   +4 more sources

HEPARIN‐INDUCED THROMBOCYTOPENIA

BJU International, 2007
Each year, 25% of all hospitalized patients are affected by venous thromboembolism, a disease comprising deep vein thrombosis and pulmonary embolism, that is responsible for up to 10% of all inpatient deaths (Alikhan, Peters, Wilmott, Cohen, 2004). Used in both the treatment and the prevention of venous thromboembolism, heparin is administered to more ...
openaire   +4 more sources